SOUTHERN FINANCIAL, 1.I.0 ACCT.
For the Period 8/1/13 to S/31/13
Note Unrealized Gain Loss is shown as "N. A" in cases where we do not have appropriate cost information for all tax lots comprising the position Please contact your J P Morgan learn (or additional
information.
Equity Detail
Adjusted Cost Unrealized Est. Annual Inc.
Price Quantity Value Original Cost GalnA.oss Accruec
—liW7 Yield
US Large Cap Equity
ARIAD PHARMACEUTICALS INC 18.60 16.535 000 307,551.00 290,997.40 16,553.60
04033A-10-0 ARIA
BIOGEN IDEC INC 213.02 2,099.000 448,276.90 250,454.95 199,821.95
09062X-104 BNB
FACEBOOK 1NC-A 41.29 17,500.000 722,645.00 665,000.00 67,645.00
30303M-10-2 FB
GENERAL ELECTRIC CO 23.14 23,000.000 532,220.00 496,109.06 36,110.92 17,480.00 3.28%
369604-10-3 GE
JPM VALUE ADVANTAGE FD -INSIL 24.96 78,709.170 1.964.580.88 2,000,000.00 (35,419.12) 19,992.12 1.02%
FUND 1400
4812A2-58-7 JVAI X
Total US Large Cap Equity 53,973,273.78 53,702,561.43 $270,712.36 937,472.12 0.94%
US Small/Mid Cap Equity
DEUTSCHE 8K AG LDN BRH 8.90 50,000.000 445800 00 352.529.00 92,471.00
DBL LONG ETN38
25154H-55-8 DAG
J.P Morgan Accounnage 5 of 48 Consolidated Statement Page 8
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 105116
CONFIDENTIAL SDNY_GM_00251300
EFTA01449662